Cargando…
Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada
IMPORTANCE: Approximately 1 in 7 patients with metastatic breast cancer (MBC) will receive radiotherapy for brain metastases (BRM). Significant differences in cumulative incidence of BRM by breast cancer subtype may inform future BRM screening protocols. OBJECTIVE: To describe cumulative incidence o...
Autores principales: | Wang, Xin Ye, Rosen, Michael N., Chehade, Rania, Sahgal, Arjun, Das, Sunit, Warner, Ellen, Saskin, Refik, Zhang, Bo, Soliman, Hany, Chan, Kelvin K. W., Jerzak, Katarzyna J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375172/ https://www.ncbi.nlm.nih.gov/pubmed/35960523 http://dx.doi.org/10.1001/jamanetworkopen.2022.25424 |
Ejemplares similares
-
PD-L1 expression in breast cancer brain metastases
por: Chehade, Rania, et al.
Publicado: (2022) -
Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020) -
Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis
por: Li, Alyssa Y., et al.
Publicado: (2023) -
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016) -
Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023)